Skip to main content
Skip to content
Case File
efta-efta01743919DOJ Data Set 10Correspondence

EFTA Document EFTA01743919

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01743919
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Richard Kahn ‹ > Subject: Avalanche Bio chief resigns abruptly Sent Thursday, July 23, 2015 8:50:01 PM To: Jeffrey E." leevacationegmail.com> Avalanche Bio chief resigns abruptly Jul 23 2015, 16:45 ET I About: \' alanche Biotechnologies (AAVL) I By: Douglas W. House, SA News Editor II • Avalanche Biotechnologics (NASDAQ:AAVL) CEO Thomas Chalberg, Ph.D., resigns effective today. The BOD appoints SVP of Business Operations Hans Hull as interim CEO and President. A search for a permanent successor is underway. • Shares are off a fraction after hours. Richard Kahn I IBRK Associates Inc. EFTA_R1_000351378 EFTA01743919

Technical Artifacts (1)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Domainleevacationegmail.com

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.